News & Articles

Updates include SCIEX OS 5.0, enhanced sensitivity modes, and expanded ecosystem integrations for proteomics and metabolomics workflows

New mass spectrometry platforms, combined with AI-driven analytics and scalable proteomics solutions, help scientists turn complex biology into actionable insights across research and drug development

Proteograph platform supports large-scale proteomics and AI-driven biomarker discovery workflows

Redipor microbiological media product range now available to order online in the USA for the first time

Strengthening local presence and customer support in a high-growth life sciences market

Ahead of ASMS 2026, Boone Prentice considers the technologies, pressures, and conversations shaping mass spectrometry’s next chapter

Simple one-step process converts existing plastics into sulfur-containing materials with improved degradability

Proposed regulatory approach aims to enable earlier patient access and support innovative trial designs

New giredestrant data from the lidERA study on its potential as a new standard of care for adjuvant ER-positive breast cancer across all menopausal stages

2026 Surviving Sepsis Campaign Guidelines and U.S. SEPSIS Act reinforce the need to close persistent therapeutic gaps in septic shock and improve survival through personalized, evidence-based approaches

University of Manchester scientists, part of a global team led by Stanford University, have uncovered a remarkable link between where you live and how quickly your body ages

Strategic collaboration integrates liquid handling, automation and microplate reader technologies for streamlined laboratory workflows

Integrated diagnostics and digital health platform aims to enable earlier intervention and improve outcomes in chronic kidney disease

First commercial sale of VertX, the cutting-edge, label-free live microscope module at William Morey General Hospital, enabling high‑resolution imaging of biopsies to support infection research and personalized treatment

New AI-powered FAIR-MS initiative aims to unlock value from historical mass spectrometry data

Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients

The new project invites the public to submit soil samples from chemically impacted land to investigate how soil microbes evolve to break down or transform chemical contaminants

Lumipulse G pTau 217 Plasma test supports identification of amyloid pathology in patients with cognitive decline

Strategic partnership is focused on reducing laboratory plastic waste while advancing sustainability, performance and transparency

Exploring how secondary ion mass spectrometry enables high‑resolution analysis of diffusion, ion exchange, and contamination in solids

Despite advances in biomarker testing, real-world data shows progress is not translating into treatment decisions, with the largest patient loss now occurring at the point of treatment decision

Acquisition strengthens Velaris’ position in laboratory automation with expanded gas generation and calibration expertise

FREEDOM study evaluates progesterone delivery using Callavid platform for threatened miscarriage

Elecsys pTau217 is the first single-assay blood test designed to identify or rule out amyloid pathology across primary and secondary care